India To Set Up CRISPR Innovation Centre In Bengaluru
Technology

India To Set Up CRISPR Innovation Centre In Bengaluru

A new Letter of Intent has been signed to establish a Centre of Excellence for CRISPR Innovation and Translation, aimed at harnessing advanced CRISPR technologies to convert laboratory research into real-world clinical applications. The proposed centre will act as a dedicated hub to accelerate the translation of scientific discoveries into affordable and scalable healthcare solutions.

The Jawaharlal Nehru Centre for Advanced Scientific Research, Bengaluru—an autonomous institute under the Department of Science and Technology—and Delhi-based CrisprBits Private Limited have jointly announced the initiative, marking one of India’s early public–private partnerships in CRISPR-based biotechnology. CrisprBits specialises in gene-editing platforms focused on developing cost-effective diagnostic and therapeutic solutions.

The Centre of Excellence is envisioned as a bridge between fundamental research and clinical impact, combining JNCASR’s strengths in biomedical sciences with CrisprBits’ expertise in applied gene-editing and translational technologies. By addressing the long-standing gap between laboratory innovation and bedside application, the centre aims to demonstrate how Indian scientific research can be effectively transformed into societal and clinical benefits. It is also expected to serve as a replicable national model for strengthening collaboration between academia and industry within India’s biotechnology ecosystem.

Commenting on the development, JNCASR President Umesh Waghmare said the partnership represents a landmark step for the institution, bringing together complementary capabilities in genetics, molecular and chemical biology, and computational biology. He added that the collaboration would open new pathways to deliver societal impact while contributing to national scientific and innovation missions.

A new Letter of Intent has been signed to establish a Centre of Excellence for CRISPR Innovation and Translation, aimed at harnessing advanced CRISPR technologies to convert laboratory research into real-world clinical applications. The proposed centre will act as a dedicated hub to accelerate the translation of scientific discoveries into affordable and scalable healthcare solutions. The Jawaharlal Nehru Centre for Advanced Scientific Research, Bengaluru—an autonomous institute under the Department of Science and Technology—and Delhi-based CrisprBits Private Limited have jointly announced the initiative, marking one of India’s early public–private partnerships in CRISPR-based biotechnology. CrisprBits specialises in gene-editing platforms focused on developing cost-effective diagnostic and therapeutic solutions. The Centre of Excellence is envisioned as a bridge between fundamental research and clinical impact, combining JNCASR’s strengths in biomedical sciences with CrisprBits’ expertise in applied gene-editing and translational technologies. By addressing the long-standing gap between laboratory innovation and bedside application, the centre aims to demonstrate how Indian scientific research can be effectively transformed into societal and clinical benefits. It is also expected to serve as a replicable national model for strengthening collaboration between academia and industry within India’s biotechnology ecosystem. Commenting on the development, JNCASR President Umesh Waghmare said the partnership represents a landmark step for the institution, bringing together complementary capabilities in genetics, molecular and chemical biology, and computational biology. He added that the collaboration would open new pathways to deliver societal impact while contributing to national scientific and innovation missions.

Next Story
Infrastructure Transport

Chennai Airport T2 Phase II Review Held

The Ministry of Civil Aviation (MoCA) Secretary Samir Kumar Sinha on Monday chaired a high-level review meeting to assess progress on the New Integrated Terminal Building T2 Phase II project at Chennai International Airport. During the meeting, officials were firmly directed to ensure that the nationally important project is completed without any delay. The Secretary instructed the Airports Authority of India (AAI), Larsen & Toubro (L&T) and the Project Management Consultant (PMC) to work in close coordination and resolve all pending issues immediately so that the terminal expansion is deliver..

Next Story
Infrastructure Urban

Auto Components Up 6.8 Per Cent In H1 FY26

India’s auto component industry grew 6.8 per cent year-on-year to Rs 3.56 trillion (USD 42.7 billion) during April–September FY26, compared with Rs 3.33 trillion (USD 40.0 billion) in the same period last year, according to the Automotive Component Manufacturers Association (ACMA). The expansion was supported by steady domestic demand, a resilient aftermarket and continued investment in capacity, localisation and technology upgrades. Sales to OEMs rose 7.3 per cent to Rs 3.04 trillion (USD 36.5 billion), driven largely by passenger vehicles and light commercial vehicles. The aftermarket p..

Next Story
Infrastructure Transport

Air India, SIA Plan JV On India–Singapore Routes

Air India and Singapore Airlines (SIA) will move towards a joint business agreement to deepen collaboration on services between India and Singapore, aimed at strengthening connectivity and enhancing customer offerings across both networks. As a first step, the two carriers signed a commercial co-operation framework agreement on Friday, according to industry sources. The proposed arrangement, similar to a commercial joint venture, will see the airlines coordinate schedules, pricing, sales and marketing on India–Singapore routes, subject to anti-trust approvals. The partnership is expected to..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Open In App